Occam Recruits Senior Pharma Executive to the Board of Geron
In March 2019, Occam Global placed Elizabeth G. O’Farrell on the Board of Geron Corporation, a publicly traded commercial-stage oncology biotech. Liz brings over 24 years of experience as a senior executive of Eli Lilly and Company, recently serving as Chief Procurement Officer. She is active on several boards, including Karius, Genmab, LENSAR, and PDL BioPharma.
Ms. O'Farrell holds a BS in accounting with honors and an MBA in Management Information Systems from Indiana University.
Occam Global is a biotech executive search, recruiting, and leadership advisory firm with specialties across technological fields, including Biotech, TechBio, AI-ML, Cell/Gene Therapy, Diagnostics/Genomics, Medical Devices, Research Tools, Digital Health, Alternative Energy, AgTech, EdTech, Robotics as well as adjacencies within Venture Capital and Private Equity. Occam helps build biotech executive leadership teams that meet the demands of the rapidly developing, competitive, and challenging industries it serves. Occam Global recruits leading C-Suite executives and board members for the most exciting and innovative clients across the world with a specific focus on the UK, Continental Europe, the US, and Asia.